All three models highlight deteriorating momentum, noting that SMCI has failed to reclaim the $38.68 resistance and is now trading below its 4-hour SMA20 within a broader bearish tech regime (XLK -1.73%). The models agree that the path of least resistance is lower toward the $31-$32 high-volume node if the $34.94 support fails, especially as MACD histograms show a bearish zero-cross. Unique risks include the lack of fresh catalysts to offset stale earnings data and macro uncertainty surrounding the upcoming NFP event and month-end de-risking.
All three models identify a high-probability mean-reversion setup as SMCI tests a confluence of support between $34.94 and $35.81, supported by an oversold 30-minute RSI of 29.73. The fundamental floor is anchored by a massive Q4 earnings beat (EPS $1.70 vs $0.96) and strong FY2027 revenue guidance of $14.5-15.5B, which two models argue provides a valuation floor at a 7.0x forward P/E. Analysts expect a bounce toward the $38.00 resistance area over a 1-3 week timeframe, further supported by the resolution of export-control investigations without material penalties.
SMCI is rolling over with 4h and 1day MACD both bearish (1day bearish zero-cross) , RSI falling, and price below the 4h SMA20, inside a bearish equity regime with tech under performing (XLK -1.73%) and TLT confirming risk-off. A break of the tightly-clustered 4h/1day support band ( $35.58/ $34.94) opens a path toward the $31- $32 high-volume node region as month-end de-risking continues into the NFP macro event. The short works on acceptance below support with momentum already deteriorating.
SMCI has sold off -3.57% into a confluence support zone: 1-day support $34.94 and SMA20 $35.81 with 30-min RSI at 29.7 and price below the lower Bollinger band, signaling short-term exhaustion. The long cohort carries a favorable shrunk 60.5% win rate with a prior winning mechanism on support retests, and the Aug 11 earnings beat (FY26 rev $39.1B, strong Q1 FY27 guide) underpins a fundamental floor at a cheap 7.0x fwd P/E. A bounce off support back toward the $37-38.5 volume-profile POC/resistance is the expected path over 1-3 weeks.
SMCI is breaking down from its post-earnings range after failing at the $38.68 4h resistance level, with deteriorating momentum across all timeframes (4h RSI falling to 47.3, MACD histogram negative and declining) . The broader market regime has shifted bearish with coordinated tech under performance (XLK -1.73%) , and the Aug 21 prior long trade failed at the same resistance zone — that failure is now confirmed as price breaks below the 4h SMA20. With no fresh company catalyst to reverse the slide and NFP event risk adding macro uncertainty, the path of least resistance is lower toward the 1day support zone at $34.94 and below.
SMCI is pulling back to test the 4-hour support zone at $35.58 after a prior rally from $28.12, with the 30-minute RSI at 29.73 (oversold) creating an exhaustion-driven bounce setup at a defined support level. The company reported a massive Q4 earnings beat (EPS $1.70 vs $0.96 est) and guided Q1 FY2027 revenue of $14.5-15.5B, providing fundamental tailwinds that the market has temporarily sold into. The expected path is a mean-reversion bounce from the 4h support toward the $38.00 resistance area over 1-3 weeks, with the oversold condition and prior support-retest winning mechanism supporting the long case.
SMCI is positioned for a short swing trade due to its technical breakdown from key resistance levels and weakening momentum in a broader bearish regime. The stock has failed to reclaim its 4h resistance at $38.68, with RSI and MACD both trending lower, signaling a loss of upside participation. The broader market regime has shifted to bearish, with tech under performing and no fresh SMCI-specific catalysts to justify a reversal. The recent earnings beat is now stale, and the stock is trading near its high-volume node at $37.74, a level that has historically acted as resistance. With volume depressed and no immediate support until $34.94, the path of least resistance is lower.
SMCI presents a compelling long setup driven by a recent pullback to a critical support zone, aligning with a broader bearish regime shift that has seen exaggerated selling in high-beta tech names. The stock is currently testing the $35.58-$34.94 support area on the 4h and 1day timeframes, respectively, with RSI nearing oversold levels (29.73 on the 30m timeframe) and MACD histogram showing signs of stabilization after a prolonged decline. The August 11 earnings report, which delivered a 77.1% EPS beat and raised FY2027 revenue guidance, provides a fundamental catalyst for a rebound, particularly as the market digests the completion of the March 2026 export-control investigation without material penalties. This setup is further supported by cross-asset confirmation from XLK, which is also pulling back but holding key support, suggesting sector-level mean reversion.